
Sign up to save your podcasts
Or
Jian Zuo, CEO of Ting Therapeutics, discusses the latest updates on otoprotective agents for three conditions: antibiotic-induced hearing loss, cisplatin-induced hearing loss, and noise-induced hearing loss. Dr. Zuo explains the science behind the company's innovative drug candidates and how they aim to address the unmet need for hearing protection.
5
11 ratings
Jian Zuo, CEO of Ting Therapeutics, discusses the latest updates on otoprotective agents for three conditions: antibiotic-induced hearing loss, cisplatin-induced hearing loss, and noise-induced hearing loss. Dr. Zuo explains the science behind the company's innovative drug candidates and how they aim to address the unmet need for hearing protection.
32,109 Listeners
4,228 Listeners
9,520 Listeners
68,440 Listeners
16 Listeners
14,670 Listeners
4,810 Listeners